Literature DB >> 19769014

Associations of chronic obstructive pulmonary disease with all-cause mortality in Blacks and Whites: the atherosclerosis risk in communities (ARIC) study.

Alanna M Chamberlain1, Matthew B Schabath, Aaron R Folsom.   

Abstract

OBJECTIVE: To determine the burden of chronic obstructive pulmonary disease (COPD) on all-cause mortality in Blacks and Whites from four US communities.
METHODS: We determined prospectively the risk of death through December 2004 in relation to baseline (1987-1989) COPD status in 10,333 Black and White participants of the Atherosclerosis Risk in Communities (ARIC) study.
RESULTS: Over a mean follow-up of 15 years (maximum 18 years), 462 deaths occurred in Blacks and 1221 deaths occurred in Whites. Hazard ratios for all-cause mortality among Blacks and Whites were similar (hazard ratio [HR] = 1.74 in Blacks and HR = 1.59 in Whites), indicating a 59%-74% greater risk of mortality for those with COPD. However, for both those with and without COPD, crude death rates were approximately double in Blacks compared to Whites.
CONCLUSIONS: Our findings suggest that given COPD, Blacks and Whites have the same proportionate increase in mortality and that the difference in death rates between Blacks and Whites cannot be explained by COPD status. The public health burden of COPD is enormous, and strategies to reduce COPD and smoking could have a large impact on total mortality rates of both Blacks and Whites.

Entities:  

Mesh:

Year:  2009        PMID: 19769014      PMCID: PMC2826210     

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  20 in total

Review 1.  Racial and ethnic differences in access to medical care.

Authors:  R M Mayberry; F Mili; E Ofili
Journal:  Med Care Res Rev       Date:  2000       Impact factor: 3.929

2.  Chronic obstructive pulmonary disease: current burden and future projections.

Authors:  A D Lopez; K Shibuya; C Rao; C D Mathers; A L Hansell; L S Held; V Schmid; S Buist
Journal:  Eur Respir J       Date:  2006-02       Impact factor: 16.671

3.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.

Authors:  Lorcan P McGarvey; Matthias John; Julie A Anderson; Michael Zvarich; Robert A Wise
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

4.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

5.  Social class and premature mortality among men: a method for state-based surveillance.

Authors:  E Barnett; D L Armstrong; M L Casper
Journal:  Am J Public Health       Date:  1997-09       Impact factor: 9.308

6.  The effect of anthropometric and socioeconomic factors on the racial difference in lung function.

Authors:  R I Harik-Khan; J L Fleg; D C Muller; R A Wise
Journal:  Am J Respir Crit Care Med       Date:  2001-11-01       Impact factor: 21.405

7.  Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  David M Mannino; Dennis E Doherty; A Sonia Buist
Journal:  Respir Med       Date:  2006-01       Impact factor: 3.415

8.  Blue-collar normative spirometric values for Caucasian and African-American men and women aged 18 to 65.

Authors:  H W Glindmeyer; J J Lefante; C McColloster; R N Jones; H Weill
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

Review 10.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405

View more
  4 in total

1.  Race and Sex Differences in Mortality in Individuals with Chronic Obstructive Pulmonary Disease.

Authors:  Jamuna K Krishnan; Mangala Rajan; Samprit Banerjee; Sonal G Mallya; MeiLan K Han; David M Mannino; Fernando J Martinez; Monika M Safford
Journal:  Ann Am Thorac Soc       Date:  2022-10

2.  Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results.

Authors:  Miron A Bogdan; Hisamichi Aizawa; Yoshinosuke Fukuchi; Michiaki Mishima; Masaharu Nishimura; Masakazu Ichinose
Journal:  BMC Pulm Med       Date:  2011-11-15       Impact factor: 3.317

3.  Chronic obstructive pulmonary disease and subsequent overall and lung cancer mortality in low-income adults.

Authors:  Melinda C Aldrich; Heather M Munro; Michael Mumma; Eric L Grogan; Pierre P Massion; Timothy S Blackwell; William J Blot
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 4.  Epidemiology of chronic obstructive pulmonary disease: a literature review.

Authors:  Catherine E Rycroft; Anne Heyes; Lee Lanza; Karin Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.